 What we've heard from them is that there's a number of reasons. One, it's historically been what they've used for approving other drugs. So it's difficult to change that precedent. The other thing is that when we give an immunosuppressive drug, we're trying initially to prevent the rejection of the organ. So they want to make sure that they continue immunosuppressive.